Tamiflu use extended

The lower age limit for use of Tamiflu (oseltamivir) has been reduced from one year to six months of age when treating flu during a pandemic. Prophylactic use of the drug is not recommended under one year. The capsule SPCs now also provide instructions for preparing extemporaneous oral 10mg/ml or 15mg/ml solutions from capsules when the powder for oral suspension is unavailable.

View Tamiflu drug record

Further information: Roche


To sign up for the MIMS monthly news update, register at www.mims.co.uk/bulletins.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Learn about neurological aspects of 'long COVID’ at a MIMS Learning webinar

Learn about neurological aspects of 'long COVID’ at a MIMS Learning webinar

Loss of taste and smell and neurological aspects of...

First triple combination MDI licensed for asthma

First triple combination MDI licensed for asthma

Trimbow (beclometasone/formoterol/glycopyrronium) can...